Document is current
Any future updates will be listed below
-
Authors
He, Yi
Sand, Jannie M B
Kubo, Satoshi
Ohkubo, Naoaki
Miyazaki, Yusuke
Karsdal, Morten
Tanaka, Yoshiya
Bay-Jensen, Anne-Christine
-
Funding
Funding for this research was provided by:
Grants-in-Aid for Scientific Research (23K15360 and 23K15359)
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 8 March 2025
First Online: 19 March 2025
Declarations
:
: This research was reviewed and approved by the Ethics Committee of Medical Research, University of Occupational and Environmental Health, Japan (approval number: H26-043). The study was conducted in compliance with the Declaration of Helsinki. All subjects provided signed consent forms.
: Not applicable.
: Author YH, JS, MK, and ACBJ are employees of Nordic Bioscience and own stocks in Nordic Bioscience. S. Kubo has received speaking fees from Eli Lilly, Bristol-Myers, GlaxoSmithKline, Abbvie, and also research grants from Daiichi-Sankyo, Abbvie, and Boehringer Ingelheim. Y. Miyazaki has received consulting fees from Astra-Zeneca, speaking fees, and/or honoraria from Eli Lilly and GlaxoSmithKline. Y. Tanaka has received speaker fees and/or honoraria from Eli Lilly, AstraZeneca, Abbvie, Gilead, Chugai, Behringer-Ingelheim, GlaxoSmithKline, Eisai, Taisho, Bristol-Myers, Pfizer, Taiho, received research grants from Mitsubishi-Tanabe, Eisai, Chugai, Taisho.
